Your browser doesn't support javascript.
loading
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
Brilakis, Emmanouil S; Mashayekhi, Kambis; Tsuchikane, Etsuo; Abi Rafeh, Nidal; Alaswad, Khaldoon; Araya, Mario; Avran, Alexandre; Azzalini, Lorenzo; Babunashvili, Avtandil M; Bayani, Baktash; Bhindi, Ravinay; Boudou, Nicolas; Boukhris, Marouane; Bozinovic, Nenad Z; Bryniarski, Leszek; Bufe, Alexander; Buller, Christopher E; Burke, M Nicholas; Büttner, Heinz Joachim; Cardoso, Pedro; Carlino, Mauro; Christiansen, Evald H; Colombo, Antonio; Croce, Kevin; Damas de Los Santos, Felix; De Martini, Tony; Dens, Joseph; Di Mario, Carlo; Dou, Kefei; Egred, Mohaned; ElGuindy, Ahmed M; Escaned, Javier; Furkalo, Sergey; Gagnor, Andrea; Galassi, Alfredo R; Garbo, Roberto; Ge, Junbo; Goel, Pravin Kumar; Goktekin, Omer; Grancini, Luca; Grantham, J Aaron; Hanratty, Colm; Harb, Stefan; Harding, Scott A; Henriques, Jose P S; Hill, Jonathan M; Jaffer, Farouc A; Jang, Yangsoo; Jussila, Risto; Kalnins, Artis.
Afiliação
  • Brilakis ES; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).
  • Mashayekhi K; Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).
  • Tsuchikane E; Toyohashi Heart Center, Aichi, Japan (E.T.).
  • Abi Rafeh N; St. George Hospital University Medical Center, Beirut, Lebanon (N.A.R.).
  • Alaswad K; Henry Ford Hospital, Detroit, MI (K.A.).
  • Araya M; Clínica Alemana and Instituto Nacional del Tórax, Santiago, Chile (M.A.).
  • Avran A; Arnault Tzank Institut St. Laurent Du Var Nice, France (A.A.).
  • Azzalini L; Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).
  • Babunashvili AM; Department of Cardiovascular Surgery, Center for Endosurgery and Lithotripsy, Moscow, Russian Federation (A.M.B.).
  • Bayani B; Cardiology Department, Mehr Hospital, Mashhad, Iran (B.B.).
  • Bhindi R; Department of Cardiology, Royal North Shore Hospital and Kolling Institute, University of Sydney, Australia (R.B.).
  • Boudou N; Rangueil University Hospital, Toulouse, France (N.B.).
  • Boukhris M; Cardiology department, Abderrahment Mami Hospital, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia (M.B.).
  • Bozinovic NZ; Department of Interventional Cardiology Clinic for Cardiovascular Diseases University Clinical Center Nis, Serbia (N.Z.B.).
  • Bryniarski L; II Department of Cardiology and Cardiovascular Interventions Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland (L.B.).
  • Bufe A; Department of Cardiology, Heartcentre Niederrhein, Helios Clinic Krefeld, Krefeld, Germany, Institute for Heart and Circulation Research, University of Cologne, Germany, and University of Witten/Herdecke, Witten, Germany (A.B.).
  • Buller CE; St. Michael's Hospital, Toronto, ON, Canada (C.E.B.).
  • Burke MN; Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, MN (E.S.B., M.N.B.).
  • Büttner HJ; Department of Cardiology and Angiology II University Heart Center Freiburg Bad Krozingen, Germany (K.M., H.J.B.).
  • Cardoso P; Cardiology Department, Santa Maria University Hospital (CHULN), Lisbon Academic Medical Centre (CAML) and Centro Cardiovascular da Universidade de Lisboa (CCUL), Portugal (P.C.).
  • Carlino M; Interventional Cardiology Division, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy (L.A., M.C.).
  • Christiansen EH; Department of Cardiology, Aarhus University Hospital, Denmark (E.H.C.).
  • Colombo A; San Raffaele Hospital and Columbus Hospital, Milan, Italy (A.C.).
  • Croce K; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (K.C.).
  • Damas de Los Santos F; Interventional Cardiology Department, Instituto Nacional de Cardiología Ignacio Chávez Mexico City, Mexico (F.D.d.l.S.).
  • De Martini T; SIU School of Medicine, Memorial Medical Center, Springfield, IL (T.D.M.).
  • Dens J; Department of Cardiology, Hospital Oost-Limburg, Genk, Belgium (J.D.).
  • Di Mario C; Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy (C.D.M.).
  • Dou K; Center for Coronary Heart Disease, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (K.D.).
  • Egred M; Freeman Hospital and Newcastle University, Newcastle upon Tyne, United Kingdom (M.E.).
  • ElGuindy AM; Department of Cardiology, Aswan Heart Center, Egypt (A.M.E.).
  • Escaned J; National Heart and Lung Institute, Imperial College London, United Kingdom (A.M.E.).
  • Furkalo S; Hospital Clinico San Carlos IDISSC and Universidad Complutense de Madrid, Spain (J.E.).
  • Gagnor A; Department of Endovascular Surgery and Angiography, National Institute of Surgery and Transplantology of AMS of Ukraine, Kiev (S.F.).
  • Galassi AR; Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy (A.G.).
  • Garbo R; Chair of Cardiology, Department of PROMISE, University of Palermo, Italy (A.R.G.).
  • Ge J; Director of Interventional Cardiology, San Giovanni Bosco Hospital, Turin, Italy (R.G.).
  • Goel PK; Zhongshan Hospital, Fudan University, Shanghai, China (J.G.).
  • Goktekin O; Sanjay Gandhi Post Graduate Institute of Medical Sciences Lucknow, India (P.K.G.).
  • Grancini L; Memorial Hospital, Istanbul, Turkey (O.G.).
  • Grantham JA; Centro Cardiologico Monzino, IRCCS, Milan, Italy (L.G.).
  • Hanratty C; Saint Luke's Mid America Heart Institute, Kansas City, MO (J.A.G.).
  • Harb S; Belfast Health and Social Care Trust, United Kingdom (C.H., S.W.).
  • Harding SA; LKH Graz II, Standort West, Kardiologie, Teaching Hospital of the University of Graz, Austria (S.H.).
  • Henriques JPS; Wellington Hospital, Capital and Coast District Health Board, New Zealand (S.A.H.).
  • Hill JM; Academic Medical Centre of the University of Amsterdam, The Netherlands (J.P.S.H.).
  • Jaffer FA; King's College Hospital, London, United Kingdom (J.M.H.).
  • Jang Y; Cardiology Division, Massachusetts General Hospital, Boston (F.A.J.).
  • Jussila R; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea (Y.J.).
  • Kalnins A; Helsinki Heart Hospital, Finland (R.J.).
Circulation ; 140(5): 420-433, 2019 07 30.
Article em En | MEDLINE | ID: mdl-31356129
Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have improved because of advancements in equipment and techniques. With global collaboration and knowledge sharing, we have identified 7 common principles that are widely accepted as best practices for CTO-PCI. 1. Ischemic symptom improvement is the primary indication for CTO-PCI. 2. Dual coronary angiography and in-depth and structured review of the angiogram (and, if available, coronary computed tomography angiography) are key for planning and safely performing CTO-PCI. 3. Use of a microcatheter is essential for optimal guidewire manipulation and exchanges. 4. Antegrade wiring, antegrade dissection and reentry, and the retrograde approach are all complementary and necessary crossing strategies. Antegrade wiring is the most common initial technique, whereas retrograde and antegrade dissection and reentry are often required for more complex CTOs. 5. If the initially selected crossing strategy fails, efficient change to an alternative crossing technique increases the likelihood of eventual PCI success, shortens procedure time, and lowers radiation and contrast use. 6. Specific CTO-PCI expertise and volume and the availability of specialized equipment will increase the likelihood of crossing success and facilitate prevention and management of complications, such as perforation. 7. Meticulous attention to lesion preparation and stenting technique, often requiring intracoronary imaging, is required to ensure optimum stent expansion and minimize the risk of short- and long-term adverse events. These principles have been widely adopted by experienced CTO-PCI operators and centers currently achieving high success and acceptable complication rates. Outcomes are less optimal at less experienced centers, highlighting the need for broader adoption of the aforementioned 7 guiding principles along with the development of additional simple and safe CTO crossing and revascularization strategies through ongoing research, education, and training.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Oclusão Coronária / Intervenção Coronária Percutânea Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Oclusão Coronária / Intervenção Coronária Percutânea Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article